drugset / Trial / NCT03514719

PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE)

NCT03514719

NaSingle-groupOpen-labelDiagnostic

Summary

In this feasibility study, a zirconium-89 (89Zr)-avelumab positron emission tomography (PET) scan will be performed in 37 patients prior to treatment with avelumab to: 1. assess the tumor and systemic tissue uptake 89Zr-avelumab 2. assess the potential to predict avelumab treatment response

Timeline

Start
2018-10-01
Primary completion
2021-09-15
Completion
2021-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Avelumab Monoclonal antibody 10 mg/kg Intravenous